Status:
COMPLETED
Human Milk Nutrients and Infants' Health Outcomes in South China
Lead Sponsor:
Huilian Zhu
Conditions:
Healthy
Eligibility:
All Genders
4-5 years
Brief Summary
The purpose of this study is to investigate the associations between human milk nutrients and infants' health outcomes in China.
Detailed Description
Human milk components are beneficial to the growth and development of infants, such as phospholipids, gangliosides, sialic acids, choline, oligosaccharide and so on. However, studies on the associatio...
Eligibility Criteria
Inclusion
- age 4-5 years
- healthy children
- breastfeeding between 0 to 400 days of age
- human milk components in human milk being determined
- sign informed consent
Exclusion
- children with severe chronic diseases, such as tumor, severe digestive diseases, kidney diseases
- gestational diabetes, hypertension and other metabolic diseases
- children with mental system diseases
- children with congenital and genetic diseases
- children with infectious diseases, eg, upper respiratory tract infection or diarrhea
- antibiotic or other drugs influencing intestinal flora being taken within 45 days
- Withdraw withdraw informed consent serious violation of the scheme no longer meet the research criteria because of health factors or accidents
Key Trial Info
Start Date :
June 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05432180
Start Date
June 6 2022
End Date
December 30 2023
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University
Guangzhou, Guangdong, China, 510080